Versant Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $407K | Buy |
10,589
+4,273
| +68% | +$164K | 0.06% | 227 |
|
|
2025
Q1 | $245K | Buy |
6,316
+6,228
| +7,077% | +$241K | 0.04% | 354 |
|
|
2024
Q4 | $2.98K | Buy |
88
+22
| +33% | +$744 | ﹤0.01% | 1959 |
|
|
2024
Q3 | $2.7K | Buy |
66
+42
| +175% | +$1.72K | ﹤0.01% | 1490 |
|
|
2024
Q2 | $924 | Hold |
24
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q1 | $1.03K | Sell |
24
-676
| -97% | -$29K | ﹤0.01% | 1533 |
|
|
2023
Q4 | $25.9K | Buy |
700
+676
| +2,817% | +$25.1K | 0.01% | 403 |
|
|
2023
Q3 | $870 | Hold |
24
| – | – | ﹤0.01% | 1563 |
|
|
2023
Q2 | $855 | Hold |
24
| – | – | ﹤0.01% | 1658 |
|
|
2023
Q1 | $854 | Hold |
24
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q4 | $843 | Hold |
24
| – | – | ﹤0.01% | 1335 |
|
|
2022
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1237 |
|
|
2022
Q2 | $1K | Buy |
+24
| New | +$1K | ﹤0.01% | 1259 |
|
|
2021
Q3 | – | Sell |
-220
| Closed | -$11K | – | 1515 |
|
|
2021
Q2 | $11K | Buy |
+220
| New | +$11K | ﹤0.01% | 683 |
|
|
2020
Q4 | – | Sell |
-247
| Closed | -$11K | – | 1416 |
|
|
2020
Q3 | $11K | Hold |
247
| – | – | ﹤0.01% | 624 |
|
|
2020
Q2 | $12K | Hold |
247
| – | – | 0.01% | 568 |
|
|
2020
Q1 | $11K | Buy |
+247
| New | +$11K | 0.01% | 525 |
|
|
2018
Q1 | – | Sell |
-137
| Closed | -$6K | – | 1550 |
|
|
2017
Q4 | $6K | Buy |
+137
| New | +$6K | ﹤0.01% | 1065 |
|